Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
Renaissance Technologies
New York
| $326M | +$61.3M | 22 | 0.58% | Increased |
|
| 27 |
Invesco
Atlanta,
Georgia
| $326M | +$11.6M | 13 | 0.11% | Increased |
|
| 28 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $325M | -$8.55M | 27 | 0.48% | Reduced |
|
| 29 |
Morgan Stanley
New York
| $304M | -$42.8M | 39 | 0.1% | Reduced |
|
| 30 |
Mawer Investment Management
Calgary,
Alberta, Canada
| $304M | +$8.9M | 1 | 3.19% | Increased |
|
| 31 |
OrbiMed
New York
| $302M | -$31.4M | 12 | 3.44% | Reduced |
|
| 32 |
Manning & Napier Advisors
Fairport,
New York
| $296M | +$15.2M | 1 | 1.82% | Increased |
|
| 33 |
Bank of New York Mellon
New York
| $276M | -$16.3M | 32 | 0.08% | Reduced |
|
| 34 |
Perceptive Advisors
New York
| $266M | -$18.8M | 13 | 17.17% | Reduced |
|
| 35 |
JP Morgan Chase
New York
| $263M | -$53.4M | 21 | 0.06% | Reduced |
|
| 36 |
Point72 Asset Management
Stamford,
Connecticut
| $260M | +$70.7M | 6 | 1.83% | Increased |
|
| 37 |
Janus Henderson Investors US
Denver,
Colorado
| $242M | +$8.62M | 6 | 0.2% | Increased |
|
| 38 |
Capital World Investors
Los Angeles,
California
| $236M | -$2.14M | 3 | 0.06% | Reduced |
|
| 39 |
BlackRock Advisors
Wilmington,
Delaware
| $222M | +$34M | 28 | 0.23% | Increased |
|
| 40 |
Thomaspartners
Boston,
Massachusetts
| $219M | +$12.6M | 1 | 2.67% | Increased |
|
| 41 |
Ameriprise
Minneapolis,
Minnesota
| $216M | +$5.43M | 9 | 0.12% | Increased |
|
| 42 |
Aristotle Capital Management
Los Angeles,
California
| $214M | -$1.69M | 1 | 2.23% | Reduced |
|
| 43 |
EARNEST Partners
Atlanta,
Georgia
| $207M | +$56.5M | 2 | 2.17% | Increased |
|
| 44 |
Jennison Associates
New York
| $203M | -$5.9M | 5 | 0.22% | Reduced |
|
| 45 |
Norges Bank
Oslo,
Norway
| $202M | +$60.8M | 11 | 0.1% | Increased |
|
| 46 |
Lazard Asset Management
New York
| $198M | +$4.75M | 4 | 0.39% | Increased |
|
| 47 |
Dimensional Fund Advisors
Austin,
Texas
| $194M | -$6.59M | 13 | 0.11% | Reduced |
|
| 48 |
Cambiar Investors
Denver,
Colorado
| $176M | +$9.1M | 1 | 2.56% | Increased |
|
| 49 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
| $167M | $0 | 1 | 14.79% | Maintained |
|
| 50 |
OppenheimerFunds
New York
| $166M | +$7.01M | 8 | 0.21% | Increased |
|